AI Verdict
NUTX has stronger fundamentals based on our AI analysis.
NUTX vs MSFT Fundamental Comparison
| Metric | NUTX | MSFT |
|---|---|---|
| Revenue | $875.3M | $158.9B |
| Net Income | $70.8M | $66.2B |
| Net Margin | 8.1% | 41.7% |
| ROE | 21.5% | 16.9% |
| ROA | 7.7% | 10.0% |
| Current Ratio | 3.41x | 1.39x |
| Debt/Equity | 0.09x | 0.10x |
| EPS | $10.48 | $8.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NUTX vs MSFT: Frequently Asked Questions
Is NUTX or MSFT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NUTX has stronger fundamentals. NUTX is rated STRONG BUY (85% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.
How does NUTX compare to MSFT fundamentally?
Nutex Health Inc. has ROE of 21.5% vs MICROSOFT CORP's 16.9%. Net margins are 8.1% vs 41.7% respectively.
Which stock pays higher dividends, NUTX or MSFT?
NUTX has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NUTX or MSFT for long term?
For long-term investing, consider that NUTX has STRONG BUY rating with 85% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NUTX vs MSFT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NUTX vs MSFT, the AI consensus favors NUTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.